CareDx CDNA shares ended the last trading session 11.2% higher at $24.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

CareDx CDNA shares rallied 6.1% in the last trading session to close at $25.07. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox ...

BRISBANE, Calif., March 11, 2025--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

CareDx (CDNA) announced that AlloSure is now commercially available for pediatric heart transplant patients of all ages and patients who have ...

In a report released today, Brandon Couillard from Wells Fargo maintained a Hold rating on CareDx (CDNA – Research Report), with a price target ...

Through laboratory techniques that track quantities of mRNA, scientists can identify which genes are “turned on” and which are “turned off” in an organism’s tissue at a given time, as ...

CareDx Inc (CDNA) reports a robust 32% revenue increase and strategic expansions, while navigating potential challenges in ...